HIV remission safety check: what happens when treatment stops?

NCT ID NCT02761200

Recruiting now Knowledge-focused Sponsor: SEARCH Research Foundation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 100 HIV patients who were diagnosed early and started antiretroviral therapy (ART) right away. After they completed a research protocol that included a temporary stop of their HIV medications (called an analytic treatment interruption), they join this study for ongoing monitoring. The goal is to track safety, viral rebound, and when they need to restart ART, providing essential information for future HIV remission research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide crucial safety data to guide future HIV remission trials, potentially moving us closer to a cure.
What could go wrong: This is an observational study, not a treatment trial. It only monitors participants who have already stopped therapy, so it cannot test new interventions or guarantee any direct benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

SEARCH
RECRUITING

Bangkok, Bangkok, 10330, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.